Dr. Stephen Wrzesinski

Claim this profile

New York Oncology Hematology, P.C.

Studies Squamous Cell Carcinoma
Studies Melanoma
1 reported clinical trial
2 drugs studied

Area of expertise

1Squamous Cell Carcinoma
Stephen Wrzesinski has run 1 trial for Squamous Cell Carcinoma. Some of their research focus areas include:
Stage IV
EGFR negative
ALK negative
2Melanoma
Stephen Wrzesinski has run 1 trial for Melanoma. Some of their research focus areas include:
Stage IV
EGFR negative
ALK negative

Affiliated Hospitals

Image of trial facility.
New York Oncology Hematology, P.C.

Clinical Trials Stephen Wrzesinski is currently running

Image of trial facility.

Brentuximab Vedotin + Pembrolizumab

for Advanced Cancers

This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer. There will be several different types of cancer studied in the trial. The cancer must have spread to other parts of the body (metastatic). The study will also find out what side effects occur. A side effect is anything the treatment does besides treat cancer. This is a multi-cohort study.
Recruiting1 award Phase 27 criteria

More about Stephen Wrzesinski

Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Stephen Wrzesinski has experience with
  • Brentuximab Vedotin
  • Pembrolizumab
Breakdown of trials Stephen Wrzesinski has run
Squamous Cell Carcinoma
Melanoma
Non-Small Cell Lung Cancer

Other Doctors you might be interested in

Rahul Ravilla, MDNew York Oncology Hematology, P.C.
Nischala AmmannagariNew York Oncology Hematology, P.C.
Mihir Raval, MDNew York Oncology Hematology, P.C.

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephen Wrzesinski specialize in?
Stephen Wrzesinski focuses on Squamous Cell Carcinoma and Melanoma. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are EGFR negative.
Is Stephen Wrzesinski currently recruiting for clinical trials?
Yes, Stephen Wrzesinski is currently recruiting for 1 clinical trial in Clifton Park New York. If you're interested in participating, you should apply.
Are there any treatments that Stephen Wrzesinski has studied deeply?
Yes, Stephen Wrzesinski has studied treatments such as Brentuximab Vedotin, Pembrolizumab.
What is the best way to schedule an appointment with Stephen Wrzesinski?
Apply for one of the trials that Stephen Wrzesinski is conducting.
What is the office address of Stephen Wrzesinski?
The office of Stephen Wrzesinski is located at: New York Oncology Hematology, P.C., Clifton Park, New York 12065 United States. This is the address for their practice at the New York Oncology Hematology, P.C..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top